SNA
49
-20
RSG
48
-23
TJX
65
-4
KMI
57
4
EIX
56
2
LEN
36
-5
DAL
70
-2
CL
64
2
ADP
66
4
AIZ
76
13
SWKS
53
-15
MSI
43
6
URBN
59
-11
TRIP
52
-29
DUK
55
3
AMG
71
-3
HPE
63
-3
APD
50
3
SCHW
56
-19
WU
47
-18
SNA
49
-20
RSG
48
-23
TJX
65
-4
KMI
57
4
EIX
56
2
LEN
36
-5
DAL
70
-2
CL
64
2
ADP
66
4
AIZ
76
13
SWKS
53
-15
MSI
43
6
URBN
59
-11
TRIP
52
-29
DUK
55
3
AMG
71
-3
HPE
63
-3
APD
50
3
SCHW
56
-19
WU
47
-18
Financhill
Back

Nisun International Enterprise Development Group Co., Ltd. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
28

NISN
Nisun International Enterprise Development Group Co., Ltd.

Last Price:
$3.32
Seasonality Move:
-4.87%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$65.70
Seasonality Move:
25.93%
Sell
28
Nisun International Enterprise Development Group Co., Ltd. (NISN) is a Sell

Is Nisun International Enterprise Development Group Co., Ltd. a Buy, Sell or Hold?

  • The current Nisun International Enterprise Development Group Co., Ltd. [NISN] share price is $3.22. The Score for NISN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NISN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $67.70. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NISN Stock Price Chart

What is Nisun International Enterprise Development Group Co., Ltd.'s stock price today?

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $67.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.

NISN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 36.43 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.32 - 3.74) Sell
Bollinger Bands (100): (3.51 - 3.99) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.86 Sell
Relative Strength Index (14 RSI): 33.87 Sell
Chaikin Money Flow: -124010 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (74.34 - 86.38) Sell
Bollinger Bands (100): (44.81 - 88.99) Buy

NISN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.3 Sell
20-day SMA: 3.46 Sell
50-day SMA: 3.66 Sell
200-day SMA: 4.44 Sell
8-day EMA: 3.29 Sell
20-day EMA: 3.41 Sell
50-day EMA: 3.17 Buy
200-day EMA: 1.55 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 74.5 Sell
20-day SMA: 80.22 Sell
50-day SMA: 82.77 Sell
200-day SMA: 51.96 Buy
8-day EMA: 74.03 Sell
20-day EMA: 77.79 Sell
50-day EMA: 77.58 Sell
200-day EMA: 56.47 Buy

Nisun International Enterprise Development Group Co., Ltd. Earnings Growth & NISN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Nisun International Enterprise Development Group Co., Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):